In his speech, Alexey Tsoy noted that Kazakhstan is actively developing medical tourism and implementing innovative technologies that have already gained recognition abroad. “Today, Kazakhstan is one of the world’s main sources of uranium, and the President has identified radiopharmaceutical development as a priority. This means we can enter the export market with high-quality radiopharmaceutical products,” he emphasized.
The Head of the Medical Center also highlighted the country’s significant potential in clinical research. “We have medical facilities accredited under international JCI and ISO standards, which ensures the quality of research. This creates opportunities for collaboration with leading biotechnology companies worldwide,” he said.
Alexey Tsoy placed particular emphasis on the development of artificial intelligence. According to him, Kazakhstan has an extensive database and a high level of digitalization, making the healthcare system open to startups from around the world. “It is important to create regulatory sandboxes where businesses and government organizations can test new technologies. At the Medical Center, we are already planning to launch a server for processing medical data and testing innovative diagnostic and treatment protocols using AI,” the speaker noted.
Among examples of successful initiatives, he highlighted the project of the domestic startup MIRAI TECH, which developed AI-powered “smart insoles.” The device analyzes gait, helps detect hidden pathologies and increases rehabilitation effectiveness. The insoles are currently being implemented at the Medical Center Hospital and have already received international recognition, becoming finalists of the Silkroad Innovation Hub accelerator in Silicon Valley.
During the interactive part of the discussion, when considering possible scenarios for 2030, Alexey Tsoy selected the model of online consultations with an AI-assisted physician as the optimal balance between technological accessibility and clinical responsibility.
He also gave special attention to ethics and transparency in the adoption of AI. “A patient must be confident that digital solutions enhance the physician’s competencies rather than replace them. In healthcare, it’s not only about price or speed — it’s about the assurance that decisions are made by a professional supported by artificial intelligence. Only then will society perceive innovations positively,” the speaker stressed.
In conclusion, he noted that the Medical Center remains open to investors and developers ready to create and promote medical technologies. “We support students, startup founders and companies, provide access to our facilities and help develop new products. Kazakhstan has all the potential to become a global-level hub for medical innovation,” summarized the Head of the Medical Center of the Presidential Administration of Kazakhstan.
In his speech, Alexey Tsoy noted that Kazakhstan is actively developing medical tourism and implementing innovative technologies that have already gained recognition abroad. “Today, Kazakhstan is one of the world’s main sources of uranium, and the President has identified radiopharmaceutical development as a priority. This means we can enter the export market with high-quality radiopharmaceutical products,” he emphasized.
The Head of the Medical Center also highlighted the country’s significant potential in clinical research. “We have medical facilities accredited under international JCI and ISO standards, which ensures the quality of research. This creates opportunities for collaboration with leading biotechnology companies worldwide,” he said.
Alexey Tsoy placed particular emphasis on the development of artificial intelligence. According to him, Kazakhstan has an extensive database and a high level of digitalization, making the healthcare system open to startups from around the world. “It is important to create regulatory sandboxes where businesses and government organizations can test new technologies. At the Medical Center, we are already planning to launch a server for processing medical data and testing innovative diagnostic and treatment protocols using AI,” the speaker noted.
Among examples of successful initiatives, he highlighted the project of the domestic startup MIRAI TECH, which developed AI-powered “smart insoles.” The device analyzes gait, helps detect hidden pathologies and increases rehabilitation effectiveness. The insoles are currently being implemented at the Medical Center Hospital and have already received international recognition, becoming finalists of the Silkroad Innovation Hub accelerator in Silicon Valley.
During the interactive part of the discussion, when considering possible scenarios for 2030, Alexey Tsoy selected the model of online consultations with an AI-assisted physician as the optimal balance between technological accessibility and clinical responsibility.
He also gave special attention to ethics and transparency in the adoption of AI. “A patient must be confident that digital solutions enhance the physician’s competencies rather than replace them. In healthcare, it’s not only about price or speed — it’s about the assurance that decisions are made by a professional supported by artificial intelligence. Only then will society perceive innovations positively,” the speaker stressed.
In conclusion, he noted that the Medical Center remains open to investors and developers ready to create and promote medical technologies. “We support students, startup founders and companies, provide access to our facilities and help develop new products. Kazakhstan has all the potential to become a global-level hub for medical innovation,” summarized the Head of the Medical Center of the Presidential Administration of Kazakhstan.
Share
